# Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

> **NCT00623194** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 146 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00623194
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2016-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623194, "Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00623194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*